HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presumed retinal pericapillary astrocytic hamartoma: multimodal imaging findings of a novel hamartomatous lesion.

AbstractPURPOSE:
To describe the multimodal imaging findings of retinal lesions that clinically resemble retinal astrocytic hamartomas (RAHs), but also have unique characteristics that we believe represent a novel variant.
METHODS:
Observational study. Five eyes in five patients with solitary retinal lesion evaluated at the retina division of three institutions. We describe the multimodal imaging findings including fundus photography, fundus autofluorescence, fluorescein angiography, spectral-domain optical coherence tomography (OCT), swept-source OCT, swept-source OCT angiography and ultrasonography.
RESULTS:
The retinal lesions described shared similar appearance to RAHs but demonstrated unique features such as glistening granular appearance on fundus photographs with perivascular hyperreflectivity with OCT and OCT angiography.
CONCLUSION:
The lesions described herein appear to have unique characteristics that warrant a designation as a novel RAH variant. The name presumed retinal pericapillary astrocytic hamartoma is suggested.
AuthorsGerardo Ledesma-Gil, Juliet Essilfie, Alex Onishi, Kenneth J Wald, Yale L Fisher, Amani A Fawzi, Carol L Shields, K Bailey Freund, Jay Chhablani
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 105 Issue 12 Pg. 1711-1715 (12 2021) ISSN: 1468-2079 [Electronic] England
PMID32980819 (Publication Type: Journal Article, Observational Study)
Copyright© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Topics
  • Fluorescein Angiography (methods)
  • Fundus Oculi
  • Hamartoma (diagnostic imaging)
  • Humans
  • Multimodal Imaging
  • Optic Nerve Glioma
  • Tomography, Optical Coherence (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: